[ad_1]
In the statement published on the Competition Authority's website, It was reported that the investigation carried out regarding the enterprises in question has been concluded..
In the statement, Arveles with the decisions of the Competition Board, Sulcid, Support, Menarini Sağlık ve İlaç Sanayi Ticaret AŞ and Clasem, which include products such as Kaleidon, Side ferns, It was stated that the undertakings sent conciliation texts within the scope of the investigation carried out against Genveon İlaç Sanayi ve Ticaret AŞ, which has products such as Cistus Pastil, to determine whether they violated the Law on the Protection of Competition..
In the statement included as a result of the compromise texts in question, the following was recorded:
“to Menarini Sağlık ve İlaç Sanayi Ticaret AŞ on the grounds that it exchanged competitively sensitive information with its competitor and thus violated the law. 42 million 148 bin 808 lira, Genveon İlaç Sanayi ve Ticaret AŞ, on the grounds that Genveon İlaç Sanayi ve Ticaret AŞ was in agreement/concerted action with its competitors by making gentlemen's agreements not to hire each other's employees in the labor market and thus violated the law. 35 million 722 bin 195 It was decided to impose an administrative fine of 1.000 liras and to end the investigation with a compromise in terms of the mentioned enterprises.”
In the statement, previously to GlaxoSmithKline İlaçları Sanayi ve Ticaret AŞ within the scope of the same investigation. 33 million 321 bin 564 lira, To Abdi İbrahim İlaç Sanayi ve Ticaret AŞ 184 million 363 bin 976 lira, To Bilim Pharmaceuticals Industry and Trade Inc. 155 million 488 bin 332 lira, To Drogsan İlaçları Sanayi ve Ticaret AŞ 30 million 593 bin 234 It was reminded that an administrative fine of TL was imposed and the investigation was concluded with a compromise regarding the mentioned enterprises..
[ad_2]
Source link
